APhA DrugInfoLine (@DrugInfoLine) profile picture

APhA DrugInfoLine

@DrugInfoLine

APhA DrugInfoLine, published by the American Pharmacists Association, provides timely, relevant, interpreted drug news and information.

 Washington, DC
aphadruginfoline.com
Joined May 2011
  • Tweets936
  • Following229
  • Followers1.4K
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon19 Dec 2013
#Abrams_Royal_Pharmacy recalls all unexpired lots of #sterile_compounded_products due to lack of sterility assurance apha.us/JI8RlV
1
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon18 Dec 2013
FDA approves first #generic versions of #Cymbalta (#duloxetine) apha.us/IVlcmJ
1
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon18 Dec 2013
#ALERT: FDA warns that #methylphenidate products for #ADHD may cause #priapism apha.us/1eowIF7
2
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon18 Dec 2013
FDA approves #umeclidinium_and_vilanterol_inhalation_powder (#Anoro Ellipta) for COPD apha.us/JJ27F0
2
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon16 Dec 2013
#RECALL: Two lots of #eculizumab (#Soliris) concentrated solution for I.V. infusion #extended to hospital/user level apha.us/1hefAzM
1
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon3 Dec 2013
#ALERT: FDA warns of #serious_skin_reactions from #antiseizure drug #clobazam (#Onfi); makes labeling changes apha.us/1k7xNi3
1
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon6 Nov 2013
#ALERT: New #timing_recommendations on #low_molecular_weight_heparins: risk of spinal column bleeding, paralysis apha.us/1883LFd
1
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon1 Nov 2013
#Obinutuzumab (#Gazyva) approved for use with chlorambucil to treat #chronic_lymphocytic_leukemia (CLL) apha.us/17xRyPI
2
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon1 Nov 2013
#ALERT: Label changes to #ezogabine (#Potiga) warn of risk of retinal abnormalities, potential vision loss apha.us/1dZcOj1
2
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon1 Nov 2013
#ALERT: #Ponatinib (#Iclusig) manufacturer suspends sales due to increased reports of life-threatening blood clots apha.us/HtavH5
1
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon21 Oct 2013
#Diclofenac (#Zorvolex) approved at dosage strengths 20% lower than currently available diclofenac products apha.us/1gyyNPN
1
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon23 Oct 2013
#RECALL: #MedStream_Programmable_Pump and #MedStream_Refill_Kit may release higher drug dosage than expected apha.us/1a889tk
1
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon18 Oct 2013
#Macitentan (#Opsumit) approved for treatment of #pulmonary_arterial_hypertension apha.us/1gr2kus
1
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon17 Oct 2013
#ALERT: #Albuterol_sulfate_inhalation_solution, 0.083%, recalled due to aseptic processing simulation results apha.us/19PAxdD
1
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon15 Oct 2013
#ALERT: #Cefepime and #dextrose injection (B. Braun Medical) recalled due to visible #particulate_matter apha.us/1giDxJ8
1
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon8 Oct 2013
To alleviate #shortage, FDA approves #lipid emulsion #Clinolipid (#Baxter Healthcare) for I.V. nutrition apha.us/1csiIZ4
1
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon8 Oct 2013
#ALERT: #Acute_nonviral_hepatitis cases linked to #supplement #OxyElite_Pro (#USPlabs_LLC). apha.us/1bFMUjW
2
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon24 Sep 2013
New 15-µ/hour #dosage strength of transdermal #buprenorphine transdermal system approved (#Butrans—#PurduePharma) apha.us/1fhjhHs
1
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon24 Sep 2013
#First generic #capecitabine approved for treatment of #colorectal and #breast #cancers apha.us/17ZNSmo
1
APhA DrugInfoLine retweeted
ADIL Med Monitor (@MedicationMon) profile picture
ADIL Med Monitor@MedicationMon24 Sep 2013
#Ustekinumab (#Stelara—#Janssen Biotech) receives FDA approval to treat active #psoriatic #arthritis apha.us/19wFFoU
1
Load more